Navigation Links
Research identifies genes vital to preventing childhood leukemia
Date:7/18/2011

Researchers at The University of Western Ontario have identified genes that may be important for preventing childhood leukemia. Acute lymphoblastic leukemia (ALL) is a cancer of the blood that occurs primarily in young children. It's frequently associated with mutations or chromosomal abnormalities that arise during embryonic or fetal development. Working with mice, researchers led by Rodney DeKoter identified two key genes that appear essential in the prevention of B cell ALL, the most common form of ALL in children. The study is published online in Blood, the Journal of the American Society of Hematology. http://bloodjournal.hematologylibrary.org/content/early/2011/07/15/blood-2011-02-335539.abstract

In the study, mice were generated with mutations in two genes called PU.1 and Spi-B. Mutation of either PU.1 or Spi-B individually had little effect. Unexpectedly, mutation of both genes resulted in 100% of the mice developing B cell ALL. Eighty percent of ALL cases in children are of the B cell type. The study found PU.1 and Spi-B have unanticipated functional redundancy as "tumor suppressor" genes that prevent leukemia.

"You can think of PU.1 and Spi-B proteins as brakes on a car. If the main brake (PU.1) fails, you still have the emergency brake (Spi-B). However, if both sets of brakes fail, the car speeds out of control," explains DeKoter, an associate professor in the Department of Microbiology & Immunology at Western's Schulich School of Medicine & Dentistry. "And uncontrolled cell division is an important cause of leukemia."

PU.1 is an essential regulator in the development of the immune system, and mutations in this gene have been previously associated with human ALL. DeKoter hopes these studies will ultimately lead to improved, less toxic, therapies for childhood leukemia. Currently, about 80% of ALL patients go into complete remission when treated with aggressive chemotherapy.


'/>"/>

Contact: Kathy Wallis
kwallis3@uwo.ca
519-661-2111 x81136
University of Western Ontario
Source:Eurekalert  

Related biology news :

1. Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy
2. BGI and National Wolfberry Engineering Research Center launch Chinese wolfberry genome project
3. Genetic research confirms that non-Africans are part Neanderthal
4. UT Southwestern research reveals that significantly more genetic mutations lead to colon cancer
5. Researchers provide means of monitoring cellular interactions
6. USC researchers explore the source of empathy in the brain
7. Penn vet researchers show lymphoma drug shrinks dog tumors, could lead to human treatment
8. UWM research offers hope for treatment of cocaine addiction
9. Research links telomere length to emphysema risk
10. The first studies utilizing the Collaborative Cross mice are published in Genome Research
11. Wood products part of winning carbon-emissions equation, researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research identifies genes vital to preventing childhood leukemia
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):
(Date:9/19/2017)... ... September 19, 2017 , ... Band-LOK, LLC, ... announced today that two new patents have been allowed by the USPTO on ... Band-LOK, said, “We continue to explore additional clinically-relevant designs for both the implants ...
(Date:9/18/2017)... , a growing leader in Electronic Trial Master file solutions ... research organization, Multidisciplinary Association for Psychedelic Studies (MAPS). ... MAPS Public Benefit Corporation selects ... ... for the treatment of Posttraumatic Stress Disorder (PTSD). MAPS also reached ...
(Date:9/15/2017)... San Diego, CA (PRWEB) , ... September 15, ... ... manufacturer Grolltex, has recently closed what it calls an ‘Internal Seed B’ round ... of the company’s stock and was completed using a ‘SAFE’ documentation structure at ...
(Date:9/14/2017)... Frederick, Maryland (PRWEB) , ... ... ... today, proudly announces the launch of its CliniControl™ (CC) product portfolio, clinically-relevant ... manufacturing, accelerating clinical translation of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The ...
Breaking Biology Technology: